Attitudes and Intentions toward Use of HIV Pre-Exposure Prophylaxis (PrEP) among Adults Receiving Treatment for Opioid Use

References

• Adams, L. M., & Balderson, B. H. (2016). HIV providers’ likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: A short report. AIDS Care, 28(9), 1154–1158. https://doi.org/10.1080/09540121.2016.1153595
   PubMed Web of Science ®Google Scholar
• Aday, L. A., & Cornelius, L. J. (2006). Designing and conducting health surveys. Jossey-Bass.
   Google Scholar
• Allen, S. T., O’Rourke, A., White, R. H., Smith, K. C., Weir, B., Lucas, G. M., Sherman, S. G., & Grieb, S. M. (2020). Barriers and facilitators to PrEP use among people who inject drugs in rural Appalachia: A qualitative study. AIDS and Behavior, 24(6), 1942–1950. https://doi.org/10.1007/s10461-019-02767-3
   PubMed Web of Science ®Google Scholar
• Alreck, P. L., & Settle, R. B. (2004). The survey research handbook, 3rd Ed. The McGraw-Hill Companies, Inc.
   Google Scholar
• Anderson, P. L., Glidden, D. V., Liu, A., Buchbinder, S., Lama, J. R., Guanira, J. V., McMahan, V., Bushman, L. R., Casapia, M., Montoya-Herrera, O., Veloso, V. G., Mayer, K. H., Chariyalertsak, S., Schechter, M., Bekker, L.-G., Kallas, E. G., & Grant, R. M. (2012). Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Science Translational Medicine, 4(151), 151ra125. https://doi.org/10.1126/scitranslmed.3004006
   PubMed Web of Science ®Google Scholar
• Andrew, B. J., Mullan, B. A., de Wit, J. B., Monds, L. A., Todd, J., & Kothe, E. J. (2016). Does the Theory of Planned Behaviour explain condom use behaviour among men who have sex with men? A meta-analytic review of the literature. AIDS and Behavior, 20(12), 2834–2844. https://doi.org/10.1007/s10461-016-1314-0
   PubMed Web of Science ®Google Scholar
• Baeten, J. M., Donnell, D., Mugo, N. R., Ndase, P., Thomas, K. K., Campbell, J. D., Wangisi, J., Tappero, J. W., Bukusi, E. A., Cohen, C. R., Katabira, E., Ronald, A., Tumwesigye, E., Were, E., Fife, K. H., Kiarie, J., Farquhar, C., John-Stewart, G., Kidoguchi, L., … Celum, C. (2014). Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: An update of data from a randomised, double-blind, phase 3 trial. The Lancet. Infectious Diseases, 14(11), 1055–1064. https://doi.org/10.1016/S1473-3099(14)70937-5
   PubMed Web of Science ®Google Scholar
• Ball, L. J., Puka, K., Speechley, M., Wong, R., Hallam, B., Wiener, J. C., Koivu, S., & Silverman, M. S. (2019). Sharing of injection drug preparation equipment is associated with HIV infection: A cross-sectional study. Journal of Acquired Immune Deficiency Syndromes, 81(4), e99–e103. https://doi.org/10.1097/QAI.0000000000002062
   PubMed Web of Science ®Google Scholar
• Bazzi, A. R., Biancarelli, D. L., Childs, E., Drainoni, M. L., Edeza, A., Salhaney, P., Mimiaga, M. J., & Biello, K. B. (2018). Limited knowledge and mixed interest in pre-exposure prophylaxis for HIV prevention among people who inject drugs. AIDS Patient Care and STDs, 32(12), 529–537. https://doi.org/10.1089/apc.2018.0126
   PubMed Web of Science ®Google Scholar
• Biello, K. B., Bazzi, A. R., Mimiaga, M. J., Biancarelli, D. L., Edeza, A., Salhaney, P., Childs, E., & Drainoni, M. L. (2018). Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs. Harm Reduction Journal, 15(1), 55. https://doi.org/10.1186/s12954-018-0263-5
   PubMed Web of Science ®Google Scholar
• Biello, K. B., Mimiaga, M. J., Valente, P. K., Saxena, N., & Bazzi, A. R. (2021). The past, present, and future of PrEP implementation among people who use drugs. Current HIV/AIDS Reports, 18(4), 328–338. https://doi.org/10.1007/s11904-021-00556-z
   PubMed Web of Science ®Google Scholar
• Bullinger, J., Reyniers, T., Vuylsteke, B., Laga, M., & Nostlinger, C. (2019). Congruence between hypothetical willingness to use pre-exposure prophylaxis (PrEP) and eligibility: An online survey among Belgian men having sex with men. International Journal of Environmental Research and Public Health. 16(22), 4411.
   PubMed Web of Science ®Google Scholar
• Campbell, A. N., Tross, S., & Calsyn, D. A. (2013). Substance use disorders and HIV/AIDS prevention and treatment intervention: Research and practice considerations. Social Work in Public Health, 28(3-4), 333–348. https://doi.org/10.1080/19371918.2013.774665
   PubMed Web of Science ®Google Scholar
• Carley, T., Siewert, E., & Naresh, A. (2019). Interest in pre-exposure prophylaxis (PrEP) for HIV is limited among women in a general obstetrics & gynecology setting. AIDS and Behavior, 23(10), 2741–2748. https://doi.org/10.1007/s10461-019-02529-1
   PubMed Web of Science ®Google Scholar
• Carter, G., Meyerson, B., Rivers, P., Crosby, R., Lawrence, C., Cope, S. D., DeBruicker, D., Levin, S., Meeks, W., Thomas, C., Turner, B., Abert, C., Coles, H., Allen, A., Gonzalez-Fagoaga, E., & Grivois-Shah, R. (2021). Living at the Confluence of Stigmas: PrEP awareness and feasibility among people who inject drugs in two predominantly rural states. AIDS and Behavior, 25(10), 3085–3096. https://doi.org/10.1007/s10461-021-03304-x
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). (2012). HIV infection and HIV-associated behaviors among injecting drug users-20 cities, United States, 2009. Morbidity and Mortality Weekly Report, 61(8), 133–146.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). (2014a). HIV Surveillance Report: Diagnoses of HIV Infection in the United States and Dependent Areas, 2013. U.S. Department of Health and Human Services. https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2013-vol-25.pdf.
   Google Scholar
• Centers for Disease Control and Prevention (CDC). (2014b). National HIV Behavioral Surveillance (NHBS), Round 4 (2014–2016). U.S. Department of Health and Human Services. https://www.cdc.gov/hiv/pdf/statistics/systems/nhbs/cdc-nhbs-crq-idu4-deployed.pdf.
   Google Scholar
• Centers for Disease Control and Prevention (CDC). (2017). Preexposure Prophylaxis for the Prevention of HIV Infection in the United States - 2017 Update: A Clinical Practice Guideline. U.S. Department of Health and Human Services. https://www.cdc.gov/hiv/pdf/guidelines/PrEPguidelines2017.pdf.
   Google Scholar
• Centers for Disease Control and Prevention (CDC). (2018). HIV Surveillance Report, 2017. U.S. Department of Health and Human Services. https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2017-vol-29.pdf.
   Google Scholar
• Centers for Disease Control and Prevention (CDC). (2019). HIV Surveillance Report, 2019. U.S. Department of Health and Human Services. https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2018-updated-vol-32.pdf.
   Google Scholar
• Centers for Disease Control and Prevention (CDC). (2021). Preexposure Prophylaxis for the Prevention of HIV Infection in the United States – 2021 Update: A Clinical Practice Guideline. U.S. Department of Health and Human Services. https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2021.pdf.
   Google Scholar
• Centers for Disease Control and Prevention (CDC). (2022). Ending the HIV Epidemic in the U.S. (EHE). U.S. Department of Health and Human Services. https://www.cdc.gov/endhiv/index.html.
   Google Scholar
• Choopanya, K., Martin, M., Suntharasamai, P., Sangkum, U., Mock, P. A., Leethochawalit, M., Chiamwongpaet, S., Kitisin, P., Natrujirote, P., Kittimunkong, S., Chuachoowong, R., Gvetadze, R. J., McNicholl, J. M., Paxton, L. A., Curlin, M. E., Hendrix, C. W., & Vanichseni, S. (2013). Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): A randomised, double-blind, placebo-controlled phase 3 trial. Lancet, 381(9883), 2083–2090. https://doi.org/10.1016/S0140-6736(13)61127-7
   PubMed Web of Science ®Google Scholar
• Davis, A. K., & Rosenberg, H. (2016). Using the Theory of Planned Behavior to predict implementation of harm reduction strategies among MDMA/ecstasy users. Psychology of Addictive Behaviors, 30(4), 500–508. https://doi.org/10.1037/adb0000167
   PubMed Web of Science ®Google Scholar
• DeMio, T. (2018). CDC called in to investigate HIV surges in the Cincinnati region. Cincinnati Enquirer.
   Google Scholar
• Donnell, D., Baeten, J. M., Bumpus, N. N., Brantley, J., Bangsberg, D. R., Haberer, J. E., Mujugira, A., Mugo, N., Ndase, P., Hendrix, C., & Celum, C. (2014). HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention. Journal of Acquired Immune Deficiency Syndromes, 66(3), 340–348. https://doi.org/10.1097/QAI.0000000000000172
   PubMed Web of Science ®Google Scholar
• Earlywine, J. J., Bazzi, A. R., Biello, K. B., & Klevens, R. M. (2021). High prevalence of indications for pre-exposure prophylaxis among people who inject drugs in Boston, Massachusetts. American Journal of Preventive Medicine, 60(3), 369–378. https://doi.org/10.1016/j.amepre.2020.09.011
   PubMed Web of Science ®Google Scholar
• Edelman, E. J., Moore, B. A., Calabrese, S. K., Berkenblit, G., Cunningham, C., Patel, V., Phillips, K., Tetrault, J. M., Shah, M., Fiellin, D. A., & Blackstock, O. (2017). Primary care physicians’ willingness to prescribe HIV pre-exposure prophylaxis for people who inject drugs. AIDS and Behavior, 21(4), 1025–1033. https://doi.org/10.1007/s10461-016-1612-6
   PubMed Web of Science ®Google Scholar
• Eggers, S. M., Mathews, C., Aaro, L. E., McClinton-Appollis, T., Bos, A. E., & de Vries, H. (2017). Predicting primary and secondary abstinence among adolescent boys and girls in the Western Cape, South Africa. AIDS and Behavior, 21(5), 1417–1428. https://doi.org/10.1007/s10461-016-1438-2
   PubMed Web of Science ®Google Scholar
• Escudero, D. J., Kerr, T., Wood, E., Nguyen, P., Lurie, M. N., Sued, O., & Marshall, B. D. (2015). Acceptability of HIV pre-exposure prophylaxis (PrEP) among people who inject drugs (PWID) in a Canadian setting. AIDS and Behavior, 19(5), 752–757. https://doi.org/10.1007/s10461-014-0867-z
   PubMed Web of Science ®Google Scholar
• Espada, J. P., Morales, A., Guillen-Riquelme, A., Ballester, R., & Orgiles, M. (2016). Predicting condom use in adolescents: A test of three socio-cognitive models using a structural equation modeling approach. BMC Public Health, 16(1), 35. https://doi.org/10.1186/s12889-016-2702-0
   PubMed Web of Science ®Google Scholar
• Fonner, V. A., Kennedy, C. E., O’Reilly, K. R., & Sweat, M. D. (2014). Systematic assessment of condom use measurement in evaluation of HIV prevention interventions: Need for standardization of measures. AIDS and Behavior, 18(12), 2374–2386. https://doi.org/10.1007/s10461-013-0655-1
   PubMed Web of Science ®Google Scholar
• Franssens, D., Hospers, H. J., & Kok, G. (2009). Social-cognitive determinants of condom use in a cohort of young gay and bisexual men. AIDS Care, 21(11), 1471–1479. https://doi.org/10.1080/09540120902883127
   PubMed Web of Science ®Google Scholar
• Golub, S. A., Gamarel, K. E., Rendina, H. J., Surace, A., & Lelutiu-Weinberger, C. L. (2013). From efficacy to effectiveness: Facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care and STDs, 27(4), 248–254. https://doi.org/10.1089/apc.2012.0419
   PubMed Web of Science ®Google Scholar
• Greiner, M. G., Shulman, M., Choo, T. H., Scodes, J., Pavlicova, M., Campbell, A. N. C., Novo, P., Fishman, M., Lee, J. D., Rotrosen, J., & Nunes, E. V. (2021). Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse. Journal of Substance Abuse Treatment, 2021 Dec;131:108447. https://doi.org/10.1016/j.jsat.2021.108447.
   Web of Science ®Google Scholar
• Hannaford, A., Lipshie-Williams, M., Starrels, J. L., Arnsten, J. H., Rizzuto, J., Cohen, P., Jacobs, D., & Patel, V. V. (2018). The use of online posts to identify barriers to and facilitators of HIV pre-exposure prophylaxis (PrEP) among men who have sex with men: A comparison to a systematic review of the peer-reviewed literature. AIDS and Behavior, 22(4), 1080–1095. https://doi.org/10.1007/s10461-017-2011-3
   PubMed Web of Science ®Google Scholar
• Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009). Research electronic data capture (REDCap) – A metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics, 42(2), 377–381. https://doi.org/10.1016/j.jbi.2008.08.010
   PubMed Web of Science ®Google Scholar
• Hoenigl, M., Jain, S., Moore, D., Collins, D., Sun, X., Anderson, P. L., Corado, K., Blumenthal, J. S., Daar, E. S., Milam, J., Dube, M. P., & Morris, S. (2018). Substance use and adherence to HIV preexposure prophylaxis for men who have sex with men. Emerging Infectious Diseases, 24(12), 2292–2302. https://doi.org/10.3201/eid2412.180400
   PubMed Web of Science ®Google Scholar
• Holloway, I. W., Tan, D., Gildner, J. L., Beougher, S. C., Pulsipher, C., Montoya, J. A., Plant, A., & Leibowitz, A. (2017). Facilitators and barriers to pre-exposure prophylaxis willingness among young men who have sex with men who use geosocial networking applications in California. AIDS Patient Care and STDs, 31(12), 517–527. https://doi.org/10.1089/apc.2017.0082
   PubMed Web of Science ®Google Scholar
• Jo, Y., Bartholomew, T. S., Doblecki-Lewis, S., Rodriguez, A., Forrest, D. W., Tomita-Barber, J., Oves, J., & Tookes, H. E. (2020). Interest in linkage to PrEP among people who inject drugs accessing syringe services; Miami, Florida. PLoS One, 15(4), e0231424. https://doi.org/10.1371/journal.pone.0231424
   PubMed Web of Science ®Google Scholar
• Jones, C. M., Byrd, D. J., Clarke, T. J., Campbell, T. B., Ohuoha, C., & McCance-Katz, E. F. (2019). Characteristics and current clinical practices of opioid treatment programs in the United States. Drug and Alcohol Dependence, 205, 107616. https://doi.org/10.1016/j.drugalcdep.2019.107616
   PubMed Web of Science ®Google Scholar
• Jones, J. T., Smith, D. K., Wiener, J., August, E. M., Finlayson, T., & Wejnert, C. (2021). Assessment of PrEP awareness, PrEP discussion with a provider, and PrEP use by transmission risk group with an emphasis on the Southern United States. AIDS and Behavior, 25(9), 2985–2991. https://doi.org/10.1007/s10461-021-03164-5
   PubMed Web of Science ®Google Scholar
• Kidd, J. D., Tross, S., Pavlicova, M., Hu, M. C., Campbell, A. N. C., & Nunes, E. V. (2017). Sociodemographic and substance use disorder determinants of HIV sexual risk behavior in men and women in outpatient drug treatment in the NIDA National Drug Abuse Treatment Clinical Trials Network. Substance Use & Misuse, 52(7), 858–865. https://doi.org/10.1080/10826084.2016.1264971
   PubMed Web of Science ®Google Scholar
• King, K. M., Nguyen, H. V., Kosterman, R., Bailey, J. A., & Hawkins, J. D. (2012). Co-occurrence of sexual risk behaviors and substance use across emerging adulthood: Evidence for state- and trait-level associations. Addiction, 107(7), 1288–1296. https://doi.org/10.1111/j.1360-0443.2012.03792.x
   PubMed Web of Science ®Google Scholar
• Kowalczyk Mullins, T. L., Braverman, P. K., Dorn, L. D., Kollar, L. M., & Kahn, J. A. (2010). Adolescent preferences for human immunodeficiency virus testing methods and impact of rapid tests on receipt of results. The Journal of Adolescent Health, 46(2), 162–168. https://doi.org/10.1016/j.jadohealth.2009.06.015
   PubMed Web of Science ®Google Scholar
• Kuo, I., Olsen, H., Patrick, R., Phillips, G., 2nd, Magnus, M., Opoku, J., Rawls, A., Peterson, J., Hamilton, F., Kharfen, M., & Greenberg, A. (2016). Willingness to use HIV pre-exposure prophylaxis among community-recruited, older people who inject drugs in Washington, DC. Drug and Alcohol Dependence, 164, 8–13. https://doi.org/10.1016/j.drugalcdep.2016.02.044
   PubMed Web of Science ®Google Scholar
• Loue, S., Sajatovic, M., & Mendez, N. (2011). Substance use and HIV risk in a sample of severely mentally Ill Puerto Rican women. Journal of Immigrant and Minority Health, 13(4), 681–689. https://doi.org/10.1007/s10903-011-9452-y
   PubMed Web of Science ®Google Scholar
• Martin, M., Vanichseni, S., Suntharasamai, P., Sangkum, U., Mock, P. A., Chaipung, B., Worrajittanon, D., Leethochawalit, M., Chiamwongpaet, S., Kittimunkong, S., Gvetadze, R. J., McNicholl, J. M., Paxton, L. A., Curlin, M. E., Holtz, T. H., Samandari, T., & Choopanya, K. (2017). Factors associated with the uptake of and adherence to HIV pre-exposure prophylaxis in people who have injected drugs: An observational, open-label extension of the Bangkok Tenofovir Study. The Lancet HIV, 4(2), e59–e66. https://doi.org/10.1016/S2352-3018(16)30207-7
   PubMed Web of Science ®Google Scholar
• Mathers, B. M., Degenhardt, L., Phillips, B., Wiessing, L., Hickman, M., Strathdee, S. A., Wodak, A., Panda, S., Tyndall, M., Toufik, A., & Mattick, R. P. (2008). Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review. Lancet, 372(9651), 1733–1745. https://doi.org/10.1016/S0140-6736(08)61311-2
   PubMed Web of Science ®Google Scholar
• McFarland, W., Lin, J., Santos, G. M., Arayasirikul, S., Raymond, H. F., & Wilson, E. (2020). Low PrEP awareness and use among people who inject drugs, San Francisco, 2018. AIDS and Behavior, 24(5), 1290–1293. https://doi.org/10.1007/s10461-019-02682-7
   PubMed Web of Science ®Google Scholar
• Moñtano, D. E., & Kasprzyk, D. (2008). Theory of reasoned action, theory of planned behavior, and the integrated behavior model. In K. Glanz, B. Rimer, & K. Viswanath (Eds.). Health behavior and health education: Theory, research, and practice (4h ed.). Jossey-Bass.
   Google Scholar
• Mullins, T. K., Braverman, P. K., Dorn, L. D., Kollar, L. M., & Kahn, J. A. (2012). Adolescents’ agreement to test for HIV when different testing methods are offered. International Journal of STD & AIDS, 23(3), 173–176. https://doi.org/10.1258/ijsa.2009.009035
   PubMed Web of Science ®Google Scholar
• Mullins, T. L., Lally, M., Zimet, G., & Kahn, J. A. (2015). Clinician attitudes toward CDC interim pre-exposure prophylaxis (PrEP) guidance and operationalizing PrEP for adolescents. AIDS Patient Care and STDs, 29(4), 193–203. https://doi.org/10.1089/apc.2014.0273
   PubMed Web of Science ®Google Scholar
• Mullins, T. L., Zimet, G., Lally, M., & Kahn, J. A. (2016). Adolescent human immunodeficiency virus care providers’ attitudes toward the use of oral pre-exposure prophylaxis in youth. AIDS Patient Care and STDs, 30(7), 339–348. https://doi.org/10.1089/apc.2016.0048
   PubMed Web of Science ®Google Scholar
• Mullins, T. L. K., Idoine, C. R., Zimet, G. D., & Kahn, J. A. (2019). Primary care physician attitudes and intentions toward the use of HIV pre-exposure prophylaxis in adolescents in one metropolitan region. The Journal of Adolescent Health, 64(5), 581–588. https://doi.org/10.1016/j.jadohealth.2018.10.300
   PubMed Web of Science ®Google Scholar
• Mullins, T. L. K., Zimet, G., Lally, M., Xu, J., Thornton, S., & Kahn, J. A. (2017). HIV care providers’ intentions to prescribe and actual prescription of pre-exposure prophylaxis to at-risk adolescents and adults. AIDS Patient Care and STDs, 31(12), 504–516. https://doi.org/10.1089/apc.2017.0147
   PubMed Web of Science ®Google Scholar
• National Institute on Drug Abuse. (2012a). Drug Abuse and HIV. U.S. Department of Health and Human Services. http://www.drugabuse.gov/sites/default/files/rrhiv.pdf.
   Google Scholar
• National Institute on Drug Abuse. (2012b). HIV/AIDS and Drug Abuse: Intertwined epidemics. U.S. Department of Health and Human Services. http://www.drugabuse.gov/sites/default/files/drugfacts_hiv_aids_0.pdf.
   Google Scholar
• Ni, Z., Altice, F. L., Wickersham, J. A., Copenhaver, M. M., DiDomizio, E. E., Nelson, L. E., & Shrestha, R. (2021). Willingness to initiate pre-exposure prophylaxis (PrEP) and its use among opioid-dependent individuals in drug treatment. Drug and Alcohol Dependence, 219, 108477. https://doi.org/10.1016/j.drugalcdep.2020.108477
   PubMed Web of Science ®Google Scholar
• Okafor, C. N., Hucks-Ortiz, C., Hightow-Weidman, L. B., Magnus, M., Emel, L., Beauchamp, G., Kuo, I., Hendrix, C., Mayer, K. H., & Shoptaw, S. J. (2020). Brief Report: Associations Between Self-Reported Substance Use Behaviors and PrEP Acceptance and Adherence Among Black MSM in the HPTN 073 Study. Journal of Acquired Immune Deficiency Syndromes, 85(1), 23–29. https://doi.org/10.1097/QAI.0000000000002407
   PubMed Web of Science ®Google Scholar
• Oldenburg, B., & Glanz, K. (2008). Diffusion of innovations. In K. Glanz, B. K. Rimer, & K. Viswanath (Eds.). Health behavior and health education (4th ed.) Jossey-Bass.
   Google Scholar
• Patel, P., Borkowf, C. B., Brooks, J. T., Lasry, A., Lansky, A., & Mermin, J. (2014). Estimating per-act HIV transmission risk: A systematic review. AIDS, 28(10), 1509–1519. https://doi.org/10.1097/QAD.0000000000000298
   PubMed Web of Science ®Google Scholar
• Picard, J., Jacka, B., Hoj, S., Laverdiere, E., Cox, J., Roy, E., & Bruneau, J. (2020). Real-world eligibility for HIV pre-exposure prophylaxis among people who inject drugs. AIDS and Behavior, 24(8), 2400–2408. https://doi.org/10.1007/s10461-020-02800-w
   PubMed Web of Science ®Google Scholar
• Qin, Y., Price, C., Rutledge, R., Puglisi, L., Madden, L. M., & Meyer, J. P. (2020). Women’s decision-making about PrEP for HIV prevention in drug treatment contexts. Journal of the International Association of Providers of AIDS Care, 19, 2325958219900091. https://doi.org/10.1177/2325958219900091
   Google Scholar
• Rao, A., Tobin, K., Davey-Rothwell, M., & Latkin, C. A. (2017). Social desirability bias and prevalence of sexual HIV risk behaviors among people who use drugs in Baltimore, Maryland: Implications for identifying individuals prone to underreporting sexual risk behaviors. AIDS and Behavior, 21(7), 2207–2214. https://doi.org/10.1007/s10461-017-1792-8
   PubMed Web of Science ®Google Scholar
• Roth, A., Tran, N., Piecara, B., Welles, S., Shinefeld, J., & Brady, K. (2019). Factors associated with awareness of pre-exposure prophylaxis for HIV among persons who inject drugs in Philadelphia: National HIV Behavioral Surveillance, 2015. AIDS and Behavior, 23(7), 1833–1840. https://doi.org/10.1007/s10461-018-2293-0
   PubMed Web of Science ®Google Scholar
• Roth, A. M., Tran, N. K., Felsher, M., Gadegbeku, A. B., Piecara, B., Fox, R., Krakower, D. S., Bellamy, S. L., Amico, K. R., Benitez, J. A., & Van Der Pol, B. (2021). Integrating HIV preexposure prophylaxis with community-based syringe services for women who inject drugs: Results from the Project SHE Demonstration Study. Journal of Acquired Immune Deficiency Syndromes, 86(3), e61–e70. https://doi.org/10.1097/QAI.0000000000002558
   PubMed Web of Science ®Google Scholar
• Schneider, K. E., White, R. H., O’Rourke, A., Kilkenny, M. E., Perdue, M., Sherman, S. G., Grieb, S. M., & Allen, S. T. (2021). Awareness of and interest in oral pre-exposure prophylaxis (PrEP) for HIV prevention and interest in hypothetical forms of PrEP among people who inject drugs in rural West Virginia. AIDS Care, 33(6), 721–728. https://doi.org/10.1080/09540121.2020.1822506
   PubMed Web of Science ®Google Scholar
• Sherman, S. G., Schneider, K. E., Park, J. N., Allen, S. T., Hunt, D., Chaulk, C. P., & Weir, B. W. (2019). PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland. Drug and Alcohol Dependence, 195, 148–155. https://doi.org/10.1016/j.drugalcdep.2018.08.014
   PubMed Web of Science ®Google Scholar
• Shrestha, R., Altice, F. L., Huedo-Medina, T. B., Karki, P., & Copenhaver, M. (2017). Willingness to use pre-exposure prophylaxis (PrEP): An empirical test of the information-motivation-behavioral skills (IMB) Model among high-risk drug users in treatment. AIDS and Behavior, 21(5), 1299–1308. https://doi.org/10.1007/s10461-016-1650-0
   PubMed Web of Science ®Google Scholar
• Shrestha, R., Karki, P., Altice, F. L., Huedo-Medina, T. B., Meyer, J. P., Madden, L., & Copenhaver, M. (2017b). Correlates of willingness to initiate pre-exposure prophylaxis and anticipation of practicing safer drug- and sex-related behaviors among high-risk drug users on methadone treatment. Drug and Alcohol Dependence, 173, 107–116. https://doi.org/10.1016/j.drugalcdep.2016.12.023
   PubMed Web of Science ®Google Scholar
• Smith, D. K., Herbst, J. H., Zhang, X., & Rose, C. E. (2015). Condom effectiveness for HIV prevention by consistency of use among men who have sex with men in the United States. Journal of Acquired Immune Deficiency Syndromes, 68(3), 337–344. https://doi.org/10.1097/QAI.0000000000000461
   PubMed Web of Science ®Google Scholar
• Smith, D. K., Van Handel, M., Wolitski, R. J., Stryker, J. E., Hall, H. I., Prejean, J., Koenig, L. J., & Valleroy, L. A. (2015). Vital Signs: Estimated percentages and numbers of adults with indications for preexposure prophylaxis to prevent HIV acquisition–United States, 2015. Morbidity and Mortality Weekly Report, 64(46), 1291–1295. https://doi.org/10.15585/mmwr.mm6446a4
   PubMed Web of Science ®Google Scholar
• Stein, M., Thurmond, P., & Bailey, G. (2014). Willingness to use HIV pre-exposure prophylaxis among opiate users. AIDS and Behavior, 18(9), 1694–1700. https://doi.org/10.1007/s10461-014-0778-z
   PubMed Web of Science ®Google Scholar
• Strathdee, S. A., Shoptaw, S., Dyer, T. P., Quan, V. M., & Aramrattana, A. (2012). Towards combination HIV prevention for injection drug users: Addressing addictophobia, apathy and inattention. Current Opinion in HIV and AIDS, 7(4), 320–325. https://doi.org/10.1097/COH.0b013e32835369ad
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. (2014). Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. U.S. Department of Health and Human Services. https://www.samhsa.gov/data/report/results-2013-national-survey-drug-use-and-health-summary-national-findings.
   Google Scholar
• Substance Abuse and Mental Health Services Administration. (2015). Substance use disorders. U.S. Department of Health and Human Services. http://www.samhsa.gov/disorders/substance-use.
   Google Scholar
• Teitelman, A. M., Chittamuru, D., Koblin, B. A., Davis, A., Brawner, B. M., Fiore, D., Broomes, T., Ortiz, G., Lucy, D., & Tieu, H. V. (2020). Beliefs associated with intention to use PrEP among cisgender U.S. women at elevated HIV risk. Archives of Sexual Behavior, 49(6), 2213–2221. https://doi.org/10.1007/s10508-020-01681-3
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration. (2017). TRUVADA® (emtricitabine/tenofovir disoproxil fumarate) tablets Package Labeling. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021752s053lbl.pdf.
   Google Scholar
• U.S. Food and Drug Administration. (2019). DESCOVY® (emtricitabine and tenofovir alafenamide) tablets Package Labeling. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208215s012lbl.pdf.
   Google Scholar
• U.S. Food and Drug Administration. (2021). APRETUDE (cabotegravir extended-release injectable suspension) Package Labeling. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215499s000lbl.pdf.
   Google Scholar
• Vederhus, J. K., Zemore, S. E., Rise, J., Clausen, T., & Hoie, M. (2015). Predicting patient post-detoxification engagement in 12-step groups with an extended version of the theory of planned behavior. Addiction Science & Clinical Practice, 10(1), 15. https://doi.org/10.1186/s13722-015-0036-3
   PubMedGoogle Scholar
• Walters, S. M., Kral, A. H., Simpson, K. A., Wenger, L., & Bluthenthal, R. N. (2020). HIV pre-exposure prophylaxis prevention awareness, willingness, and perceived barriers among people who inject drugs in Los Angeles and San Francisco, CA, 2016–2018. Substance Use & Misuse, 55(14), 2409–2419. https://doi.org/10.1080/10826084.2020.1823419
   PubMed Web of Science ®Google Scholar
• Weller, S., & Davis, K. (2002). Condom effectiveness in reducing heterosexual HIV transmission. The Cochrane Database of Systematic Reviews, 2002(1), CD003255. https://doi.org/10.1002/14651858.CD003255
   Google Scholar
• Zemore, S. E., & Ajzen, I. (2014). Predicting substance abuse treatment completion using a new scale based on the theory of planned behavior. Journal of Substance Abuse Treatment, 46(2), 174–182. https://doi.org/10.1016/j.jsat.2013.06.011
   PubMed Web of Science ®Google Scholar